Reuters logo
Royalty Pharma handed May deadline to make firm Elan offer
April 3, 2013 / 11:21 AM / 4 years ago

Royalty Pharma handed May deadline to make firm Elan offer

DUBLIN, April 3 (Reuters) - U.S. investment firm Royalty Pharma must either announce an offer for Irish drugmaker Elan by May 10 or not proceed with a $6.6 billion approach, Ireland’s Takeover Panel said on Wednesday.

Elan has rejected Royalty’s indicative approach, worth $11 per Elan share, and welcomed the takeover panel’s imposition of a deadline, reiterating that the “highly conditional indication of interest” was opportunistic in its timing.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below